Trials / Completed
CompletedNCT00719030
A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
A Randomized, Placebo-controlled, Pre-surgical Study of the Effects of Pomegranate Pills in Men With Prostate Cancer Prior to Radical Prostatectomy
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Jonsson Comprehensive Cancer Center · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the effects of pomegranate polyphenol pills (POM-X) and a placebo (sugar pill) on prostatic oxidative stress. The placebo is a pill that looks like the POM-X pill but does not have an active ingredient.
Detailed description
Subjects will receive POM-X or placebo pills daily for up to 4 weeks prior to undergoing radical prostatectomy for prostate cancer. Biomarkers in the blood, urine, and prostate tissue will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Pomegranate pill | Pomegranate extract pill |
| DIETARY_SUPPLEMENT | Pomegranate pill placebo | Pomegranate pill placebo |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-04-01
- Completion
- 2012-05-01
- First posted
- 2008-07-21
- Last updated
- 2016-08-01
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00719030. Inclusion in this directory is not an endorsement.